RGNX insider filings

REGENXBIO Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-03. Screen RGNX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 7 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Ciongoli Gregory Austin — Director12 legs · 102,603 sh · $949,381—2
Chan Mitchell — Chief Financial Officer2——2
Malzahn Craig — Chief Technology Officer2——2
Christmas Patrick J. — Chief Strategy & Legal Officer1——1
PAKOLA STEVE — Chief Medical Officer1——1

Recent insider filings — REGENXBIO Inc.

FiledFormInsiderReported transactionsSource
2026-11-034Chan Mitchell — Chief Financial OfficerGrant/award (A): 24,305 @ $0EDGAR
2026-11-034PAKOLA STEVE — Chief Medical OfficerGrant/award (A): 34,722 @ $0EDGAR
2026-11-034Christmas Patrick J. — Chief Strategy & Legal OfficerGrant/award (A): 34,722 @ $0EDGAR
2026-11-034Malzahn Craig — Chief Technology OfficerGrant/award (A): 27,777 @ $0EDGAR
2026-09-034Chan Mitchell — Chief Financial OfficerTax withholding (F): 4,902 @ $9.32EDGAR
2026-09-034Malzahn Craig — Chief Technology OfficerTax withholding (F): 234 @ $9.32EDGAR
2026-08-274Ciongoli Gregory Austin — DirectorGrant/award (A): 15,432 @ $0 · Purchase (P): 49,196 @ $9.14 · Purchase (P): 53,407 @ $9.36 · Grant/award (A): 69,609 (derivative) @ $0EDGAR
2026-08-044PAKOLA STEVE — Chief Medical OfficerTax withholding (F): 7,468 @ $9.69EDGAR
2026-08-044Christmas Patrick J. — Chief Strategy & Legal OfficerTax withholding (F): 4,699 @ $9.69EDGAR
2026-07-064PAKOLA STEVE — Chief Medical OfficerOption exercise (M): 2,161 @ $7.86 · Sale (S): 2,161 @ $13.64 · Option exercise (M): 2,161 (derivative) @ $0EDGAR
2026-07-064Simpson Curran — Chief Executive Officer, DirectorGrant/award (A): 951 @ $7.00 · Grant/award (A): 1,453 @ $10.18 · Tax withholding (F): 6,818 @ $13.09EDGAR
2026-07-014PAKOLA STEVE — Chief Medical OfficerSale (S): 19,608 @ $11.04 · Option exercise (M): 36,725 @ $7.86 · Sale (S): 36,725 @ $12.86 · Option exercise (M): 36,725 (derivative) @ $0EDGAR
2026-06-024Bennett Jean — DirectorGrant/award (A): 9,807 @ $0 · Grant/award (A): 46,600 (derivative) @ $0EDGAR
2026-06-024Zachary Jennifer — DirectorGrant/award (A): 9,807 @ $0 · Grant/award (A): 46,600 (derivative) @ $0EDGAR
2026-06-024Glucksmann Alexandra — DirectorGrant/award (A): 9,807 @ $0 · Grant/award (A): 46,600 (derivative) @ $0EDGAR
2026-06-024Fox Allan M. — DirectorGrant/award (A): 9,807 @ $0 · Grant/award (A): 46,600 (derivative) @ $0EDGAR
2026-06-024Mills Kenneth T. — DirectorGrant/award (A): 9,807 @ $0 · Grant/award (A): 46,600 (derivative) @ $0EDGAR
2026-06-024Tasse Daniel — DirectorGrant/award (A): 9,807 @ $0 · Grant/award (A): 46,600 (derivative) @ $0EDGAR
2026-06-024STUMP DAVID C — DirectorGrant/award (A): 9,807 @ $0 · Grant/award (A): 46,600 (derivative) @ $0EDGAR
2026-06-024KARABELAS ARGERIS N — DirectorGrant/award (A): 9,807 @ $0 · Grant/award (A): 46,600 (derivative) @ $0EDGAR
2026-06-024MIGAUSKY GEORGE V — DirectorGrant/award (A): 9,807 @ $0 · Grant/award (A): 46,600 (derivative) @ $0EDGAR
2026-05-134PAKOLA STEVE — Chief Medical OfficerSale (S): 15,309 @ $11.02EDGAR
2026-03-124PAKOLA STEVE — Chief Medical OfficerSale (S): 5,124 @ $10.35EDGAR
2026-02-034PAKOLA STEVE — Chief Medical OfficerTax withholding (F): 5,267 @ $11.16EDGAR
2026-02-034Christmas Patrick J. — Chief Strategy & Legal OfficerTax withholding (F): 4,700 @ $11.16EDGAR
2026-01-294Mills Kenneth T. — DirectorOption exercise (M): 225,000 @ $13.09 · Tax withholding (F): 221,753 @ $13.41 · Option exercise (M): 225,000 (derivative) @ $0EDGAR
2026-01-084Malzahn Craig — Chief Technology OfficerGrant/award (A): 65,847 @ $0 · Grant/award (A): 35,402 (derivative) @ $0EDGAR
2026-01-084Chan Mitchell — Chief Financial OfficerGrant/award (A): 73,749 @ $0 · Grant/award (A): 39,650 (derivative) @ $0EDGAR
2026-01-084PAKOLA STEVE — Chief Medical OfficerGrant/award (A): 65,847 @ $0 · Grant/award (A): 35,402 (derivative) @ $0EDGAR
2026-01-084Christmas Patrick J. — Chief Strategy & Legal OfficerGrant/award (A): 73,749 @ $0 · Grant/award (A): 39,650 (derivative) @ $0EDGAR
2026-01-084Simpson Curran — Chief Executive Officer, DirectorGrant/award (A): 144,864 @ $0 · Grant/award (A): 233,651 (derivative) @ $0EDGAR
2026-01-064Malzahn Craig — Chief Technology OfficerTax withholding (F): 1,238 @ $14.40EDGAR
2026-01-064PAKOLA STEVE — Chief Medical OfficerTax withholding (F): 18,247 @ $14.40EDGAR
2026-01-064Christmas Patrick J. — Chief Strategy & Legal OfficerTax withholding (F): 9,793 @ $14.40EDGAR
2026-01-064Simpson Curran — Chief Executive Officer, DirectorTax withholding (F): 18,559 @ $14.40EDGAR
2025-10-104Simpson Curran — Chief Executive Officer, DirectorSale (S): 20,811 @ $12.62EDGAR
2025-10-014Simpson Curran — Chief Executive Officer, DirectorSale (S): 7,624 @ $10.03EDGAR
2025-09-124Simpson Curran — Chief Executive Officer, DirectorSale (S): 7,734 @ $10.02EDGAR
2025-09-034Malzahn Craig — Chief Technology OfficerTax withholding (F): 234 @ $8.93EDGAR
2025-09-034Chan Mitchell — Chief Financial OfficerTax withholding (F): 4,901 @ $8.93EDGAR
2025-08-044Christmas Patrick J. — Chief Strategy & Legal OfficerTax withholding (F): 4,699 @ $8.19EDGAR
2025-07-034Simpson Curran — Chief Executive Officer, DirectorTax withholding (F): 4,701 @ $8.23EDGAR
2025-06-034Zachary Jennifer — DirectorGrant/award (A): 7,768 @ $0 · Grant/award (A): 39,815 (derivative) @ $0EDGAR
2025-06-034Mills Kenneth T. — DirectorGrant/award (A): 7,768 @ $0 · Grant/award (A): 39,815 (derivative) @ $0EDGAR
2025-06-034Glucksmann Alexandra — DirectorGrant/award (A): 7,768 @ $0 · Grant/award (A): 39,815 (derivative) @ $0EDGAR
2025-06-034Bennett Jean — DirectorGrant/award (A): 7,768 @ $0 · Grant/award (A): 39,815 (derivative) @ $0EDGAR
2025-06-034Tasse Daniel — DirectorGrant/award (A): 7,768 @ $0 · Grant/award (A): 39,815 (derivative) @ $0EDGAR
2025-06-034STUMP DAVID C — DirectorGrant/award (A): 7,768 @ $0 · Grant/award (A): 39,815 (derivative) @ $0EDGAR
2025-06-034KARABELAS ARGERIS N — DirectorGrant/award (A): 7,768 @ $0 · Grant/award (A): 39,815 (derivative) @ $0EDGAR
2025-06-034MIGAUSKY GEORGE V — DirectorGrant/award (A): 7,768 @ $0 · Grant/award (A): 39,815 (derivative) @ $0EDGAR

Recent 8-K events — REGENXBIO Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-09-238-K1.01 — Entry into a Material Definitive AgreementEDGAR
2026-08-258-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-248-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-208-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-298-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-038-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
2026-05-148-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RGNX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs